Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Autoimmune disease drug maker Citryll has hit the first close of a targeted $19m series A, having sourced commitments from BrightGene and ModiQuest.

Keio Innovation Initiative contributed to a $20m round that increased the total funding for medical access app developer CureApp, partially based on Keio University research, to nearly $39m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Aviation Industry Corporation of China and GF Securities took part in the anti-theft and fraud software developer's latest round, which was in the eight figures.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Immuno-oncology therapy developer Century Therapeutics has emerged from stealth, having raised $250m from Leaps by Bayer, which invested $215m, and Fujifilm subsidiary FCDI.

The Tencent-backed online medicine distributor has reportedly increased its valuation to more than $1bn in a series C3 round of undisclosed size.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.